Annexon grants stock options to two new employees under inducement plan

GlobeNewswire··Read original
1▲0 ▼0Impact / 5
Summary · why it matters

Annexon announced it granted inducement equity awards to two new non-executive employees under its 2022 Employment Inducement Award Plan. The awards, approved on July 12, 2026 under Nasdaq Listing Rule 5635(c)(4), consist of options to purchase an aggregate of 335,000 shares of common stock. The options have a ten-year term, an exercise price of $6.50 per share equal to the July 15, 2026 closing price, and vest over four years with 25% vesting after one year and the remainder vesting monthly thereafter.

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks
Annexon Inc
ANNX
± MixedCapitalrelevance

Grant of inducement stock options to new employees is a routine capital event, not clearly positive or negative.